GLAS
Glass House Brands Inc.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
2.28
close · 2026-10-29
value
35
cheaper than peers35
quality
24
stronger fundamentals24
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
41 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 2.79× | 50 |
| forward P/E | 10.93× | 48 |
| price to sales | 4.55× | 26 |
3 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 43.8% | 67 |
| operating margin | -6.4% | 31 |
| revenue growth | -1.2% | 28 |
| return on equity | -28.6% | 28 |
4 of 4 measures available
Facts
| market cap | $215M |
| free cash flow | -$19.8M |
| employees | 357 |
| first trade | 2019-07-18 |
| next earnings | 2026-08-13 |
| fundamentals updated | 2026-09-02 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.55 | 0.01 | -1.37 | -0.83 |
| free cash flow | -$15.7M | $18.1M | $10.9M | -$68.6M |
| net income | -$29.7M | $519,000 | -$98.3M | -$32.9M |
| revenue | $182.0M | $200.9M | $160.8M | $84.9M |
| unusual items | -$4.3M | $8.1M | -$77.2M | $22.5M |